Kim B S, Bahk Y Y, Kang H K, Yauch R L, Kang J A, Park M J, Ponzio N M
Department of Microbiology-Immunology, Northwestern University Medical School, Chicago, IL 60611, USA.
J Immunol. 1999 Jun 15;162(12):7049-57.
Theiler's murine encephalomyelitis virus induces chronic demyelinating disease in genetically susceptible mice. The histopathological and immunological manifestation of the disease closely resembles human multiple sclerosis, and, thus, this system serves as a relevant infectious model for multiple sclerosis. The pathogenesis of demyelination appears to be mediated by the inflammatory Th1 response to viral epitopes. In this study, T cell repertoire reactive to the major pathogenic VP1 epitope region (VP1233-250) was analyzed. Diverse minimal T cell epitopes were found within this region, and yet close to 50% of the VP1-reactive T cell hybridomas used V beta 16. The majority (8/11) of the V beta 16+ T cells required the C-terminal amino acid residue on the epitope, valine at position 245, and every T cell hybridoma recognizing this C-terminal residue expressed V beta 16. However, the complementarity-determining region 3 sequences of the V beta 16+ T cell hybridomas were markedly heterogeneous. In contrast, such a restriction was not found in the V alpha usage. Only restricted residues at this C-terminal position allowed for T cell activation, suggesting that V beta 16 may recognize this terminal residue. Further functional competition analysis for TCR and MHC class II-contacting residues indicate that many different residues can be involved in the class II and/or TCR binding depending on the T cell population, even if they recognize the identical minimal epitope region. Thus, recognition of the C-terminal residue of a minimal T cell epitope may associate with a particular V beta (but not V alpha) subfamily-specific sequence, resulting in a highly restricted V beta repertoire of the epitope-specific T cells.
泰勒氏鼠脑脊髓炎病毒可在基因易感小鼠中引发慢性脱髓鞘疾病。该疾病的组织病理学和免疫学表现与人类多发性硬化症极为相似,因此,这一系统可作为多发性硬化症相关的感染模型。脱髓鞘的发病机制似乎是由针对病毒表位的炎症性Th1反应介导的。在本研究中,分析了对主要致病性VP1表位区域(VP1233 - 250)有反应的T细胞库。在该区域内发现了多种最小T细胞表位,但近50%的VP1反应性T细胞杂交瘤使用Vβ16。大多数(8/11)Vβ16 + T细胞需要表位上的C末端氨基酸残基,即245位的缬氨酸,并且每个识别该C末端残基的T细胞杂交瘤都表达Vβ16。然而,Vβ16 + T细胞杂交瘤的互补决定区3序列明显异质。相比之下,在Vα使用中未发现这种限制。只有该C末端位置的特定残基才能激活T细胞,这表明Vβ16可能识别该末端残基。对TCR和MHC II类接触残基的进一步功能竞争分析表明,即使它们识别相同的最小表位区域,根据T细胞群体的不同,许多不同的残基可能参与II类和/或TCR结合。因此,对最小T细胞表位C末端残基的识别可能与特定的Vβ(而非Vα)亚家族特异性序列相关联,导致表位特异性T细胞的Vβ库高度受限。